ESRP1 and head and neck squamous cell carcinoma: In particular, Ishii et al. showed that the down-modulation of ESRP1 in human head and neck squamous cell carcinoma cell lines (i.e., SAS and HSC4) led to the induction of RAC1b expression [18].